Wealthcare Advisory Partners LLC Sells 367 Shares of The Clorox Company $CLX

Wealthcare Advisory Partners LLC decreased its position in The Clorox Company (NYSE:CLX) by 15.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,983 shares of the company’s stock after selling 367 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in Clorox were worth $238,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in Clorox by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 15,573,076 shares of the company’s stock worth $2,293,135,000 after buying an additional 65,924 shares during the last quarter. Northern Trust Corp lifted its position in Clorox by 2.3% in the 1st quarter. Northern Trust Corp now owns 1,528,920 shares of the company’s stock worth $225,133,000 after buying an additional 34,655 shares during the last quarter. Invesco Ltd. lifted its position in Clorox by 7.4% in the 1st quarter. Invesco Ltd. now owns 1,361,710 shares of the company’s stock worth $200,512,000 after buying an additional 94,371 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Clorox by 3.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,157,257 shares of the company’s stock worth $170,406,000 after buying an additional 41,485 shares during the last quarter. Finally, Hsbc Holdings PLC lifted its position in Clorox by 118.8% in the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock worth $159,699,000 after buying an additional 589,544 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insiders Place Their Bets

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CLX shares. Wells Fargo & Company dropped their target price on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research report on Thursday, September 25th. Jefferies Financial Group lowered their price objective on Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research report on Thursday, June 26th. Citigroup lowered their price objective on Clorox from $135.00 to $130.00 and set a “neutral” rating for the company in a research report on Wednesday. Weiss Ratings reiterated a “hold (c)” rating on shares of Clorox in a research report on Saturday, September 27th. Finally, TD Cowen lowered their price objective on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $131.92.

Clorox Price Performance

Shares of CLX stock opened at $120.14 on Friday. The stock has a market cap of $14.63 billion, a price-to-earnings ratio of 18.43, a PEG ratio of 0.98 and a beta of 0.52. The business’s fifty day moving average is $122.21 and its 200 day moving average is $128.79. The Clorox Company has a twelve month low of $116.53 and a twelve month high of $171.37. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of 4.1%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio is presently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.